MapLight Therapeutics MPLT
NASDAQ MPLT
$8.47 +0.23 (+2.79%)
As of: Oct 21, 2026 · 10:36 AM EDT

MapLight Therapeutics (MPLT) Enterprise Value (2025 - 2026)

Updated

MapLight Therapeutics' Enterprise Value was $1.32 billion in Q2 2026.

Analysis

MapLight Therapeutics (MPLT) Enterprise Value (2025 - 2026) Analysis & Trends

On a trailing twelve-month basis, MapLight Therapeutics' Enterprise Value was $1.63 billion through Jun 30, 2026; for FY2025, it was -$300.58 million.

Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Eli Lilly 1,131.65 Bn 1,100.24 Bn 19.71 Bn
2 Johnson & Johnson 615.89 Bn 534.41 Bn 17.26 Bn
3 AbbVie 505.03 Bn 478.14 Bn 12.70 Bn
4 Merck 368.78 Bn 323.16 Bn 12.21 Bn
5 Novartis Ag 298.66 Bn 262.65 Bn 11.24 Bn
6 Astrazeneca 262.09 Bn 235.78 Bn 12.86 Bn
7 Amgen 236.57 Bn 191.97 Bn 7.24 Bn
8 Gilead Sciences 191.05 Bn 165.25 Bn 6.22 Bn
9 Pfizer 170.60 Bn 117.25 Bn 10.94 Bn
10 MapLight Therapeutics 384.80 Mn 384.80 Mn -
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 1.32 Bn
Dec 31, 2025 -300.58 Mn
API Access

MapLight Therapeutics Enterprise Value API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=enterprise-value&ticker=MPLT&period=max&api_key=YOUR_API_KEY